Registration Opening Soon for BOS Events 2025!

Dates for BOS Events 2025 are confirmed as 11th and 12th June for BOS Basel 2025 and 25th and 26th November for BOS Manchester 2025. Please find further details outlining provisional floor plans and pricing options at the event links provided. Note that we plan to open for registrations on Monday 4th November at 09.00 GMT.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for digital events and resources, please look out for an announcement soon on this. We look forward to welcoming you and your colleagues to BOS Events! Please contact the Bio2Business team for further details.

Featured Company (BOS Manchester 2024)

Onyx Scientific Limited
Onyx Scientific is the CDMO division of Ipca Laboratories, offering small molecule drug substance development and manufacturing services. Our MHRA-licensed sites in the UK offer early development of candidate APIs and manufacturing for clinical phases through to commercial supply. Dedicated solid-state...
View profile

Featured Speaker (BOS Manchester 2024)

Solubility Enhancing Technologies for APIs

Dr Jonathan Loughrey, Associate Director, Almac Group

ABSTRACT: Limited aqueous solubility of an API may manifest in reduced exposure during PK-tox. and DRF studies. Therefore, having access to technologies and the expertise to design and screen solubility enhancing technologies for an API may be advantageous. This presentation aims to introduce the audience to the importance of improving and maintaining aqueous drug solubility, how to devise formulation strategies for an API exhibiting challenging aqueous solubility, Almac’s technologies to improve API solubility for PK-tox. and DRF studies, and Almac’s road to GMP for such solubility enabling technol... Click here to Read More